Tag: Sickle-Cell Anemia
Increasing Dose for Total Body Irradiation Cuts Graft Failure
Findings seen in patients with severe hemoglobinopathies receiving haploidentical bone marrow transplantation
New Law Boosts Fight Against Sickle Cell Disease
In 2018, the National Institutes of Health was funded approximately $115 million for research of the disease
L-Glutamine Reduces Number of Pain Crises in Sickle Cell Disease
Significantly fewer pain crises, hospitalizations compared with those receiving placebo
Sickle Cell Trait Not Linked to Stroke in African-Americans
Meta-analysis of four cohorts shows sickle cell trait not linked to incidence of ischemic stroke
Ceruloplasmin ID’d As Marker of Kidney Disease in Sickle Cell
Findings part of proteomic analysis of urine in patients with sickle cell disease
Antibiotic Rx Adherence Varies Widely in Sickle Cell Care
Guideline-adherent therapy tied to fewer 30-day readmissions
FDA Approves Endari for the Treatment of Sickle Cell Disease
First treatment approved for patients with sickle cell disease in almost 20 years
Gene Therapy Described in a Patient With Sickle Cell Disease
But treatment has only been given to one patient so far
Sickle Cell Trait May Affect Reliability of HbA1c Readings
HbA1c levels significantly lower than in people without sickle cell trait
ASH: Lower Rate of Sickle Cell Pain Crises With Crizanlizumab
Lower rate of crises per year; longer median time to first, second crises with high-dose therapy
